Performance analysis of Aardvark Therapeutics (AARD)
Annual Return
Since Feb 13, 2025, AARD has had an average annual return of -48.57%, underperforming the benchmark SPY, which returned +16.09% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -57.87% | -8.28% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.02% | -3.86% | -69.81% | +44.02% | -24.32% | +40.15% | -4.00% | -57.87% | |||||
| 2025 | -11.04% | -41.01% | +47.94% | -6.03% | +29.50% | -11.17% | -30.89% | +60.12% | -19.56% | -6.64% | +31.52% | -8.28% |
Drawdown analysis of Aardvark Therapeutics (AARD)
The maximum drawdown for the AARD was -80.01%, occurring on Jun 10, 2026. This drawdown has not yet recovered.
The current AARD drawdown is -68.24%.
Since Feb 13, 2025 AARD has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -80.01% | Oct 7, 2025 | 169 | Jun 10, 2026 | Ongoing | Ongoing | Ongoing |
| -59.42% | Feb 20, 2025 | 40 | Apr 17, 2025 | 118 | Oct 7, 2025 | 158 |
| -7.06% | Feb 13, 2025 | 1 | Feb 14, 2025 | 2 | Feb 19, 2025 | 3 |